BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Tian T, Zhang J. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. Int J Mol Sci 2021;22:8470. [PMID: 34445193 DOI: 10.3390/ijms22168470] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Gao X, Zhou S, Qin Z, Li D, Zhu Y, Ma D. Upregulation of HMGB1 in tumor-associated macrophages induced by tumor cell-derived lactate further promotes colorectal cancer progression. J Transl Med 2023;21:53. [PMID: 36709284 DOI: 10.1186/s12967-023-03918-w] [Reference Citation Analysis]
2 Wei L, Zhao D, Sun W, Lin L, Sui D, Li W, Gui Y, Wang J, Deng Y, Song Y. Targeting of TAMs with freeze-dried monosialotetrahexosylganglioside and sialic acid-octadecylamine co-modified liposomes remodels the tumor microenvironment and enhances anti-tumor activity. Eur J Pharm Biopharm 2023:S0939-6411(23)00011-5. [PMID: 36682511 DOI: 10.1016/j.ejpb.2023.01.011] [Reference Citation Analysis]
3 Huang K, Luo W, Fang J, Yu C, Liu G, Yuan X, Liu Y, Wu W. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment. BMC Cancer 2023;23:55. [PMID: 36647017 DOI: 10.1186/s12885-023-10526-w] [Reference Citation Analysis]
4 Liu Y, Yang H, Xiong J, Zhao J, Guo M, Chen J, Zhao X, Chen C, He Z, Zhou Y, Xu L. Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective. Biomed Pharmacother 2023;157:113991. [PMID: 36370524 DOI: 10.1016/j.biopha.2022.113991] [Reference Citation Analysis]
5 Wang X, Yuwen T, Zhong Y, Li Z, Wang X. A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front. Heliyon 2023. [DOI: 10.1016/j.heliyon.2023.e13211] [Reference Citation Analysis]
6 Qi YH, Yang LZ, Zhou L, Gao LJ, Hou JY, Yan Z, Bi XG, Yan CP, Wang DP, Cao JM. Sympathetic nerve infiltration promotes stomach adenocarcinoma progression via norepinephrine/β2-adrenoceptor/YKL-40 signaling pathway. Heliyon 2022;8:e12468. [PMID: 36593854 DOI: 10.1016/j.heliyon.2022.e12468] [Reference Citation Analysis]
7 Li X, Wu Y, Tian T. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. Int J Mol Sci 2022;23. [PMID: 36430910 DOI: 10.3390/ijms232214436] [Reference Citation Analysis]
8 Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1051998] [Reference Citation Analysis]
9 Rajtmajerová M, Trailin A, Liška V, Hemminki K, Ambrozkiewicz F. Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment. Cancers 2022;14:5450. [DOI: 10.3390/cancers14215450] [Reference Citation Analysis]
10 Lopez T, Wendremaire M, Lagarde J, Duquet O, Alibert L, Paquette B, Garrido C, Lirussi F. Wound Healing versus Metastasis: Role of Oxidative Stress. Biomedicines 2022;10:2784. [DOI: 10.3390/biomedicines10112784] [Reference Citation Analysis]
11 Glass SE, Coffey RJ. Recent Advances in the Study of Extracellular Vesicles in Colorectal Cancer. Gastroenterology 2022;163:1188-97. [PMID: 35724732 DOI: 10.1053/j.gastro.2022.06.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kazemi MH, Sadri M, Najafi A, Rahimi A, Baghernejadan Z, Khorramdelazad H, Falak R. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango? Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1018962] [Reference Citation Analysis]
13 Xu G, Niu L, Wang Y, Yang G, Zhu X, Yao Y, Zhao G, Wang S, Li H. HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer. Cell Death Dis 2022;13:888. [PMID: 36270986 DOI: 10.1038/s41419-022-05335-1] [Reference Citation Analysis]
14 Grünewald S, Stecklum M, Rizzo M, Rathjens J, Fiebig L, Zopf D. Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice.. [DOI: 10.21203/rs.3.rs-2060413/v1] [Reference Citation Analysis]
15 Shan J, Han D, Shen C, Lei Q, Zhang Y. Mechanism and strategies of immunotherapy resistance in colorectal cancer. Front Immunol 2022;13:1016646. [DOI: 10.3389/fimmu.2022.1016646] [Reference Citation Analysis]
16 Cao M, Wang Y, Lu G, Qi H, Li P, Dai X, Lu J. Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer. CIMB 2022;44:4447-4471. [DOI: 10.3390/cimb44100305] [Reference Citation Analysis]
17 Huang K, Luo W, Fang J, Yu C, Liu G, Yuan X, Liu Y, Wu W. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment.. [DOI: 10.21203/rs.3.rs-1974731/v1] [Reference Citation Analysis]
18 Pu Y, Zhu J, Xu J, Zhang S, Bao Y. Antitumor effect of a polysaccharide from Pseudostellaria heterophylla through reversing tumor-associated macrophages phenotype. Int J Biol Macromol 2022;220:816-26. [PMID: 35988728 DOI: 10.1016/j.ijbiomac.2022.08.111] [Reference Citation Analysis]
19 Xing C, Du Y, Duan T, Nim K, Chu J, Wang HY, Wang R. Interaction between microbiota and immunity and its implication in colorectal cancer. Front Immunol 2022;13:963819. [DOI: 10.3389/fimmu.2022.963819] [Reference Citation Analysis]
20 Manzoor S, Muhammad JS, Maghazachi AA, Hamid Q. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance. Front Oncol 2022;12:924290. [DOI: 10.3389/fonc.2022.924290] [Reference Citation Analysis]
21 Rampado R, Biccari A, D'Angelo E, Collino F, Cricrì G, Caliceti P, Giordano F, Taraballi F, Pucciarelli S, Agostini M. Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach. Front Bioeng Biotechnol 2022;10:883034. [PMID: 35757799 DOI: 10.3389/fbioe.2022.883034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Koustas E, Trifylli EM, Sarantis P, Papadopoulos N, Karapedi E, Aloizos G, Damaskos C, Garmpis N, Garmpi A, Papavassiliou KA, Karamouzis MV, Papavassiliou AG. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives. Int J Mol Sci 2022;23:6664. [PMID: 35743107 DOI: 10.3390/ijms23126664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhang L, Cai H. Cancer Immunotherapy and Cytotoxicity: Current Advances and Challenges. Cytotoxicity [Working Title] 2022. [DOI: 10.5772/intechopen.105184] [Reference Citation Analysis]
24 Chiou YS, Lan YM, Lee PS, Lin Q, Nagabhushanam K, Ho CT, Pan MH. Piceatannol Prevents Colon Cancer Progression via Dual-Targeting to M2-Polarized Tumor-Associated Macrophages and the TGF-β1 Positive Feedback Signaling Pathway. Mol Nutr Food Res 2022;:e2200248. [PMID: 35616191 DOI: 10.1002/mnfr.202200248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Rastegari-Pouyani M, Mohammadi-Motlagh HR, Baghaei K, Mansouri K, Hajivalili M, Mostafaie A, Amani D. 2-methylpyridine-1-ium-1-sulfonate modifies tumor-derived exosome mediated macrophage polarization: Relevance to the tumor microenvironment. Int Immunopharmacol 2022;106:108581. [PMID: 35149296 DOI: 10.1016/j.intimp.2022.108581] [Reference Citation Analysis]
26 Yu DL, Lou ZP, Ma FY, Najafi M. The interactions of paclitaxel with tumour microenvironment. Int Immunopharmacol 2022;105:108555. [PMID: 35121223 DOI: 10.1016/j.intimp.2022.108555] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 Ranasinghe R, Mathai M, Zulli A. A synopsis of modern - day colorectal cancer: Where we stand. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Keenan JI, Frizelle FA. Biomarkers to Detect Early-Stage Colorectal Cancer. Biomedicines 2022;10:255. [PMID: 35203465 DOI: 10.3390/biomedicines10020255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Arora L, Kalia M, Pal D. Role of macrophages in cancer progression and targeted immunotherapies. Advances in Protein Chemistry and Structural Biology 2022. [DOI: 10.1016/bs.apcsb.2022.11.010] [Reference Citation Analysis]
30 Czajka-francuz P, Cisoń-jurek S, Czajka A, Kozaczka M, Wojnar J, Chudek J, Francuz T. Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer. IJMS 2021;23:124. [DOI: 10.3390/ijms23010124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen T, Wang Y, Nan Z, Wu J, Li A, Zhang T, Qu X, Li C. Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis. Front Immunol 2021;12:779325. [DOI: 10.3389/fimmu.2021.779325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Ålgars A, Kemppinen L, Fair-Mäkelä R, Mustonen H, Haglund C, Jalkanen S. Stage I-IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1+ Vessel Density. Cancers (Basel) 2021;13:5988. [PMID: 34885098 DOI: 10.3390/cancers13235988] [Reference Citation Analysis]
33 Shin HC, Seo I, Jeong H, Byun SJ, Kim S, Bae SU, Kwon SY, Lee HW. Prognostic Impact of Tumor-Associated Macrophages on Long-Term Oncologic Outcomes in Colorectal Cancer. Life (Basel) 2021;11:1240. [PMID: 34833118 DOI: 10.3390/life11111240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Ieni A, Caruso RA, Pizzimenti C, Giuffrè G, Irato E, Rigoli L, Navarra G, Fadda G, Tuccari G. M1 Polarized Tumor-Associated Macrophages (TAMs) as Promising Prognostic Signature in Stage I–II Gastric Adenocarcinomas. GastrointestDisord 2021;3:207-17. [DOI: 10.3390/gidisord3040020] [Reference Citation Analysis]
35 Prayugo FB, Kao TJ, Anuraga G, Ta HDK, Chuang JY, Lin LC, Wu YF, Wang CY, Lee KH. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas. Biomedicines 2021;9:1460. [PMID: 34680577 DOI: 10.3390/biomedicines9101460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]